EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
EUDA Health Holdings LimitedNASDAQ: EUDA
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses grows, but more slowly than its trailing trend
Q2 FY2026 operating expenses of $1.02M rose 3.9% year over year, behind the +182.7% change in trailing-twelve-month operating expenses. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -25.4% a year.
Context
- Operating expenses amounted to 79.7% of revenue in FY2025, down 371.5 pp from a year earlier.
- Operating expenses increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +3.9% toward the trailing-twelve-month pace of +182.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 5.43M USD
- Year-over-year change
- -70.0%
- 4-year CAGR
- +31.6%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.43M | -70.0% |
| FY2024 | 2024-12-31 | 18.1M | +276.8% |
| FY2023 | 2023-12-31 | 4.8M | -63.3% |
| FY2022 | 2022-12-31 | 13.09M | +623.2% |
| FY2021 | 2021-12-31 | 1.81M | — |
Operating Expenses vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +182.7% is the highest of 8, against a peer median of -12.9%.
- Operating expenses amounts to 76.1% of revenue for EUDA, versus a peer median of 230.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $205.81M USD | -28.7% | -15.4% | 86.7% | |
| LTM Mar 2026 | $92.88M USD | -4.0% | +25.5% | — | |
| LTM Mar 2026 | $82.81M USD | -13.0% | -1.4% | 183.7% | |
| LTM Mar 2026 | $50.96M USD | -7.1% | +11.4% | 26818.9% | |
| LTM Mar 2026 | $42.59M USD | -12.9% | -16.3% | 277.8% | |
| LTM Mar 2026 | $32.88M USD | +8.0% | +7.8% | 31.2% | |
| LTM Jun 2026 | $9.27M USD | +182.7% | -25.4% | 76.1% | |
| LTM Mar 2026 | CA$6.32M CAD | -15.4% | -31.0% | 3803.5% | |
| Peer median (excluding EUDA) | — | -12.9% | -1.4% | 230.8% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M |
| Cost of Revenue | 3.31M | 2.89M | 2.86M | 3.25M | 3.83M |
| Gross Profit | 1.25M | 870K | 842.08K | 762.16K | 2.99M |
| Gross Margin | 27.4% | 23.1% | 22.7% | 19.0% | 43.9% |
| Research & Development | 129.27K | 17.21K | 0 | 0 | 249 |
| Selling, General & Admin | 1.81M | 6.75M | 4.8M | 3.34M | 5.43M |
| Operating Expenses | 1.81M | 13.09M | 4.8M | 18.1M | 5.43M |
| Depreciation & Amortization | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K |
| EBITDA | 1.34M | (24.64M) | (8.29M) | (17.42M) | (2.09M) |
| EBITDA Margin | 29.4% | -654.6% | -223.7% | -434.4% | -30.7% |
| Operating Income | (559.99K) | (5.72M) | (3.96M) | (17.34M) | (2.44M) |
| Operating Margin | -12.3% | -151.9% | -106.9% | -432.2% | -35.8% |
| Interest Income | 1.92M | 0 | 0 | 0 | 0 |
| Interest Expense | 127.13K | 93.78K | 23.23K | 44.89K | 228.62K |
| Other Income / Expenses | 2.23M | (19.21M) | (4.47M) | (307.38K) | (285.26K) |
| Income Before Tax | 1.67M | (24.93M) | (8.43M) | (17.64M) | (2.73M) |
| Pre-Tax Margin | 36.6% | -662.3% | -227.6% | -439.8% | -40.0% |
| Income Tax Expense | 46.49K | (20.79K) | 0 | (4.38K) | 41.94K |
| Net Income | 864.83K | (24.88M) | (10.04M) | (15.36M) | (2.77M) |
| Net Margin | 19.0% | -661.1% | -270.9% | -382.9% | -40.7% |
| EPS (Basic) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| EPS (Diluted) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| Weighted Avg Shares | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
| Weighted Avg Shares (Diluted) | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.